메뉴 건너뛰기




Volumn 156, Issue 4, 2013, Pages

Long-term outcomes in ranibizumab-treated patients with retinal vein occlusion; The role of progression of retinal nonperfusion

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

EID: 84884553088     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.05.039     Document Type: Article
Times cited : (90)

References (11)
  • 2
    • 77952891051 scopus 로고    scopus 로고
    • Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study
    • P.A. Campochiaro, J.S. Heier, and L. Feiner Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study Ophthalmology 117 6 2010 1102 1112
    • (2010) Ophthalmology , vol.117 , Issue.6 , pp. 1102-1112
    • Campochiaro, P.A.1    Heier, J.S.2    Feiner, L.3
  • 3
    • 77952889477 scopus 로고    scopus 로고
    • Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion: 6-month results of the phase III CRUISE study
    • D.M. Brown, P.A. Campochiaro, and R.P. Singh Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion: 6-month results of the phase III CRUISE study Ophthalmology 117 6 2010 1124 1133
    • (2010) Ophthalmology , vol.117 , Issue.6 , pp. 1124-1133
    • Brown, D.M.1    Campochiaro, P.A.2    Singh, R.P.3
  • 4
    • 79958817527 scopus 로고    scopus 로고
    • Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study
    • D.M. Brown, P.A. Campochiaro, and R.B. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 8 2011 1594 1602
    • (2011) Ophthalmology , vol.118 , Issue.8 , pp. 1594-1602
    • Brown, D.M.1    Campochiaro, P.A.2    Bhisitkul, R.B.3
  • 5
    • 79958843614 scopus 로고    scopus 로고
    • Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: 12-month outcomes of a phase III study
    • P.A. Campochiaro, D.M. Brown, and C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 10 2011 2041 2049
    • (2011) Ophthalmology , vol.118 , Issue.10 , pp. 2041-2049
    • Campochiaro, P.A.1    Brown, D.M.2    Awh, C.C.3
  • 6
    • 78649880482 scopus 로고    scopus 로고
    • Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusion: Two-year outcomes
    • P.A. Campochiaro, G. Hafiz, and R. Channa Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusion: two-year outcomes Ophthalmology 117 12 2010 2387 2394
    • (2010) Ophthalmology , vol.117 , Issue.12 , pp. 2387-2394
    • Campochiaro, P.A.1    Hafiz, G.2    Channa, R.3
  • 7
    • 84862817252 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusions: Long term follow-up in the HORIZON trial
    • J.S. Heier, P.A. Campochiaro, and L. Yau Ranibizumab for macular edema due to retinal vein occlusions: long term follow-up in the HORIZON trial Ophthalmology 119 4 2012 802 809
    • (2012) Ophthalmology , vol.119 , Issue.4 , pp. 802-809
    • Heier, J.S.1    Campochiaro, P.A.2    Yau, L.3
  • 8
    • 0022347471 scopus 로고
    • Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1
    • Early Treatment Diabetic Retinopathy Study Research Group T.
    • The Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 12 1985 1796 1806
    • (1985) Arch Ophthalmol , vol.103 , Issue.12 , pp. 1796-1806
  • 9
    • 77956992320 scopus 로고    scopus 로고
    • Standard care vs corticosteroid for retinal vein occlusion (SCORE) study for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE study report 9
    • B.A. Blodi, A. Domalpally, and I.U. Scott Standard care vs corticosteroid for retinal vein occlusion (SCORE) study for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE study report 9 Arch Ophthalmol 128 9 2010 1140 1145
    • (2010) Arch Ophthalmol , vol.128 , Issue.9 , pp. 1140-1145
    • Blodi, B.A.1    Domalpally, A.2    Scott, I.U.3
  • 10
    • 84875752725 scopus 로고    scopus 로고
    • Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion
    • P.A. Campochiaro, R.B. Bhisitkul, H. Shapiro, and R.G. Rubio Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion Ophthalmology 120 4 2013 795 802
    • (2013) Ophthalmology , vol.120 , Issue.4 , pp. 795-802
    • Campochiaro, P.A.1    Bhisitkul, R.B.2    Shapiro, H.3    Rubio, R.G.4
  • 11
    • 0021198916 scopus 로고
    • Argon laser photocoagulation for macular edema in branch vein occlusion
    • Branch Vein Occlusion Study Group T.
    • The Branch Vein Occlusion Study Group Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 3 1984 271 282
    • (1984) Am J Ophthalmol , vol.98 , Issue.3 , pp. 271-282


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.